青蒿素概念下跌0.92%，主力资金净流出5股

Group 1 - The core viewpoint of the news is that the Artemisinin concept sector has experienced a decline, with a drop of 0.92%, ranking among the top losers in the market [1][2] - Within the Artemisinin concept sector, companies such as China Resources Double Crane, Zhejiang Medicine, and Haizheng Pharmaceutical have seen significant declines, while a few companies like Baihua Medicine, Delong Huineng, and Rundu Co., Ltd. have recorded slight increases [1][2] - The main capital outflow from the Artemisinin concept sector today was 75 million yuan, with Zhejiang Medicine experiencing the largest outflow of approximately 79.91 million yuan [2] Group 2 - The top gainers in the Artemisinin concept sector included Baihua Medicine with an increase of 0.93%, Delong Huineng with 0.51%, and Rundu Co., Ltd. with 0.14% [1][2] - The capital inflow leaders in the sector were Xinhecheng, China Resources Double Crane, and Delong Huineng, with inflows of approximately 26.70 million yuan, 12.69 million yuan, and 6.80 million yuan respectively [2] - The overall trading activity in the sector showed that Zhejiang Medicine had a turnover rate of 3.91%, while Baihua Medicine had a turnover rate of 4.72% [2]